Document is current
Any future updates will be listed below
-
Authors
Duan, Yiting
Xu, Chengquan
Wang, Wenjie
Wang, Xiaoyan
Xu, Nuo
Zhong, Jieming
Gong, Weiwei
Zheng, Weifang
Wu, Yi-Hsuan
Myers, April
Chu, Lisa
Lu, Ying
Delzell, Elizabeth
Hsing, Ann W.
Yu, Min
He, Wei
Zhu, Shankuan
-
Funding
Funding for this research was provided by:
the National Key R&D Program of China (Grant No. 2022YFC2705303, Grant No. 2022YFC2705300)
"Pioneer" and "Leading Goose" R&D Program of Zhejiang (Grant No. 2024C03180)
the Nutrilite Health Institute Wellness Fund
the Cyrus Tang Foundation
the China Medical Board
the Hsun K. Chou Fund of Zhejiang University Education Foundation
- License Information
-
More Information
Article History
Received: 6 October 2024
Accepted: 25 February 2025
First Online: 10 March 2025
Declarations
:
: The protocol of WELL-China cohort study was approved by the Institutional Review Boards of Zhejiang University (No. ZGL201507-3) and Stanford University (IRB-35020). The protocol of Lanxi cohort study received approval from the Ethics Committee of the School of Public Health, Zhejiang University (No. ZGL201905-1). Written informed consents were obtained from all participants in both cohorts.
: Not applicable.
: The authors declare no competing interests.
